On this page
Chromosome Y
The male-determining sex chromosome - small, gene-poor, and largely heterochromatic. Carries SRY, the testis-determining gene.
Schematic of chromosome Y showing the short (p) and long (q) arms. Arm ratio per GRCh38 - banding schematic.
Available at Jeen Health
Clinical tests that include this
Overview
The Y chromosome is the smallest of the 24 human chromosome types, spanning approximately 57.2 million base pairs, which represents roughly 1.9 per cent of the total genome. It encodes only around 63 protein-coding genes, far fewer than any other chromosome. The majority of the Y chromosome consists of heterochromatin - densely packed DNA that does not code for proteins and is largely transcriptionally inactive. Because the Y chromosome is inherited exclusively from father to son, it has been used extensively in population genetics and ancestry studies to trace paternal lineages across human history.
Chromosome Y is acrocentric, meaning its centromere sits near one end, creating a very short p arm and a much longer q arm. The short arm carries a small pseudoautosomal region (PAR1) that pairs and recombines with a corresponding region on the X chromosome during male meiosis, ensuring correct segregation of the sex chromosomes. The remainder of the Y chromosome does not recombine and is passed down virtually unchanged from father to son, aside from rare mutations. Clinically, chromosome Y is best known for its role in sex determination and male fertility. Abnormalities of this chromosome can result in disorders of sex development (DSD), also referred to as differences of sex development or variations in sex characteristics, infertility, or sex chromosome aneuploidies such as 47,XYY syndrome.
Because the Y chromosome is present in only half the population and carries relatively few genes, it has been subject to evolutionary pressures distinct from the autosomes. Some researchers have noted a gradual loss of genetic material from the Y chromosome over evolutionary time, though essential genes involved in sex determination and spermatogenesis remain highly conserved.
Structure
Like all chromosomes, the Y chromosome is a single, continuous molecule of double-stranded DNA packaged with histone proteins into chromatin. During cell division, this chromatin condenses dramatically to form the compact, X-shaped structure visible under a microscope at metaphase. The Y chromosome's acrocentric architecture places the centromere close to one end, yielding a short p arm (approximately 10 Mb) and a long q arm (approximately 47 Mb). The short arm includes a pseudoautosomal region, PAR1, which spans roughly 2.7 Mb and contains genes shared with the X chromosome. This region undergoes recombination with the X chromosome during meiosis in males, allowing the sex chromosomes to pair and segregate correctly.
The bulk of the Y chromosome, particularly the long arm, consists of repetitive sequences and heterochromatin that do not encode functional genes. These regions are largely composed of satellite DNA, tandem repeats, and palindromic sequences - long stretches of DNA that read the same forwards and backwards. The palindromes are thought to enable a form of 'gene conversion' that may help maintain gene function despite the absence of a homologous partner for recombination. A smaller euchromatic region on the long arm contains the genes critical for male fertility, including several members of the DAZ (deleted in azoospermia) gene family and other spermatogenesis genes clustered in the AZF regions.
Video: What is a karyotype?
Notable regions
The most clinically significant region of the Y chromosome is Yp11.2, which houses the SRY gene (sex-determining region Y). SRY encodes a transcription factor that acts as the master switch for male sex determination. Around weeks seven to eight after conception, SRY expression in the bipotential gonad triggers a cascade of downstream genes that direct the tissue to differentiate into testes rather than ovaries. Without a functional SRY gene, an embryo with a 46,XY karyotype will typically develop ovaries and a female phenotype, a condition sometimes referred to as Swyer syndrome or 46,XY complete gonadal dysgenesis. Translocations or deletions affecting SRY are rare but well-documented causes of differences in sex development.
Also at Yp11.2 lies pseudoautosomal region 1 (PAR1), a short stretch of DNA shared with the tip of the X chromosome's short arm. Genes in PAR1 escape X-inactivation in females and are expressed from both the X and Y chromosomes in males, ensuring that males and females have equivalent doses of these genes. PAR1 is essential for proper pairing and segregation of the sex chromosomes during meiosis. A second, much smaller pseudoautosomal region (PAR2) exists at the tips of the long arms of X and Y, though it is less well characterised and plays a smaller role in recombination.
The region Yq11.2 on the long arm contains the AZF (azoospermia factor) loci, subdivided into AZFa, AZFb, and AZFc. These regions harbour multiple genes involved in sperm production, including members of the DAZ gene family, RBMY, and others. Microdeletions spanning one or more of these regions are a well-recognised cause of severe male infertility, particularly non-obstructive azoospermia (the absence of sperm in the ejaculate) or severe oligozoospermia (very low sperm count). AZFc deletions are the most common, while AZFa or AZFb deletions tend to result in more profound spermatogenic failure. Testing for Y-chromosome microdeletions is offered through NHS fertility services and specialist andrology clinics for men undergoing investigation for infertility, particularly those considering assisted reproductive techniques.
Notable genes
The Y chromosome carries a small number of genes, the most famous of which is SRY. This single gene has an outsized impact, orchestrating the entire male developmental programme by initiating testis formation. Other well-known genes include the DAZ (deleted in azoospermia) gene family, which encompasses DAZ1, DAZ2, DAZ3, and DAZ4. These genes encode RNA-binding proteins that are critical for germ-cell development and are expressed exclusively in the testes. Loss of DAZ genes through microdeletion is a common genetic cause of male infertility.
USP9Y (ubiquitin-specific peptidase 9, Y-linked) is another gene important for spermatogenesis, and deletions or mutations affecting it have been implicated in some cases of azoospermia. RBMY1A1 (RNA-binding motif protein, Y-linked, family 1, member A1) is part of a multi-copy gene family involved in regulating RNA splicing during sperm production. TSPY1 (testis-specific protein, Y-encoded 1) is present in multiple copies on the Y chromosome and may play a role in germ-cell proliferation, though its precise function remains under investigation. Because these genes are found only on the Y chromosome, they cannot be compensated for by the X chromosome, making males particularly vulnerable to loss-of-function mutations or deletions in these regions.
Chromosomal disorders
Chromosomal abnormalities involving the Y chromosome most commonly manifest as differences in sex development or male infertility. One of the most frequently encountered Y-chromosome disorders is 47,XYY syndrome, also known as Jacobs syndrome. This condition arises from nondisjunction during paternal meiosis II, resulting in a supernumerary Y chromosome. Most males with 47,XYY are phenotypically normal and may never be diagnosed, though some studies suggest a slightly increased risk of learning difficulties, delayed speech and language development, and taller-than-average stature. Early studies suggesting associations with criminality have been discredited due to methodological flaws and ascertainment bias; population studies show no meaningful link between 47,XYY and criminal behaviour. More recent evidence suggests that any associations with behavioural problems are modest and highly variable. The condition is often identified incidentally during prenatal screening or investigation for developmental concerns.
Y-chromosome microdeletions are another important category of disorder, affecting an estimated one in a thousand to one in two thousand men in the general population, and present in around 10 to 15 per cent of men with non-obstructive azoospermia. These microdeletions typically affect one or more of the AZF regions (AZFa, AZFb, AZFc) and result in impaired spermatogenesis. The severity of the infertility phenotype depends on which region is deleted: AZFa and AZFb deletions generally lead to complete absence of sperm production (Sertoli-cell-only syndrome or maturation arrest), while AZFc deletions may permit some residual sperm production, occasionally allowing sperm retrieval for use in assisted reproduction. Because Y-chromosome microdeletions are passed from father to son, men who conceive using retrieved sperm and intracytoplasmic sperm injection (ICSI) will transmit the deletion to all male offspring, who may themselves experience infertility.
Other Y-chromosome anomalies include structural rearrangements such as isodicentric Y chromosomes or ring Y chromosomes, which can be associated with a spectrum of phenotypes from Turner-syndrome-like features to ambiguous genitalia or male infertility, depending on which genes are retained or lost. Complete loss of the Y chromosome in some or all cells (45,X/46,XY mosaicism) can result in mixed gonadal dysgenesis, ovotesticular differences of sex development, or Turner syndrome phenotype. These complex karyotypes are typically identified through genetic testing in children with atypical genital development or delayed puberty.
Prenatal screening & diagnosis
Abnormalities of the Y chromosome are not routinely screened for during standard antenatal care in the UK, though non-invasive prenatal testing (NIPT) can detect foetal sex and may flag sex-chromosome aneuploidies such as 47,XYY or 45,X/46,XY mosaicism if used as part of private or high-risk screening pathways. NIPT analyses cell-free foetal DNA in maternal blood and can identify the presence of Y-chromosome sequences, indicating a male fetus; sex determination by NIPT is highly accurate but may be confirmed by ultrasound, as confirmation by ultrasound or examination is standard practice. Some NIPT platforms include the option to screen for sex-chromosome aneuploidies alongside the common autosomal trisomies (Down, Edwards, Patau syndromes).
When a sex-chromosome abnormality is suspected, confirmatory testing is performed using chorionic villus sampling or amniocentesis followed by karyotyping or chromosomal microarray analysis. In cases where ultrasound identifies ambiguous genitalia or other features suggestive of a difference in sex development, targeted genetic testing for SRY and other genes may be undertaken after birth. Postnatal karyotyping or microarray is the mainstay of diagnosis for sex-chromosome aneuploidies and structural Y-chromosome anomalies. For men undergoing investigation for infertility, Y-chromosome microdeletion analysis (often performed using multiplex PCR to detect deletions in AZFa, AZFb, and AZFc) is a standard part of the NHS fertility-assessment pathway.
Inheritance & recurrence
Most Y-chromosome abnormalities arise de novo, meaning they occur as new events during gametogenesis and are not inherited from a parent. The 47,XYY karyotype, for example, typically results from a nondisjunction error during the father's meiosis II and is not inherited from the father's own karyotype. As a result, the recurrence risk for future pregnancies is generally considered to be very low, though slightly elevated above the background population risk due to the possibility of germline mosaicism.
Y-chromosome microdeletions, on the other hand, are heritable in a unique pattern. Because the Y chromosome is passed exclusively from father to son, any microdeletion present in a father will be transmitted to all male offspring. Men with AZF deletions who father sons using assisted reproductive techniques such as testicular sperm extraction and ICSI will pass the deletion to those sons, who are likely to experience similar fertility challenges. Genetic counselling is therefore an important component of fertility treatment for men with Y-microdeletions, and NHS genomic medicine services recommend discussion of the implications for future male offspring. Female offspring do not inherit the Y chromosome and are therefore unaffected, though they may carry X-linked conditions if present in the family.
Frequently asked questions
Can someone be born without a Y chromosome?
Yes. Individuals with a 46,XX karyotype (typical females) do not have a Y chromosome. Additionally, some individuals with Turner syndrome have a 45,X karyotype, meaning they have only one X chromosome and no second sex chromosome. People with certain differences in sex development may also lack a Y chromosome despite having some male characteristics, often due to translocation of the SRY gene to another chromosome.
Does the Y chromosome determine everything about being male?
The Y chromosome carries the SRY gene, which triggers testis development in the embryo, setting off a cascade of male development. However, many other genes on the autosomes and the X chromosome also contribute to male sexual development, hormone production, and secondary sexual characteristics. SRY is the initiating switch, but male biology involves the coordinated action of genes across the entire genome.
If my partner has a Y-chromosome microdeletion, what does that mean for our children?
Y-chromosome microdeletions are passed from father to son. If your partner has a deletion in the AZF regions and you conceive a male child (whether naturally or through assisted reproduction using retrieved sperm), that son will inherit the deletion and is likely to experience similar fertility challenges. Female children do not inherit the Y chromosome and will not be affected by the deletion. Genetic counselling through NHS services can help you understand the implications for your family.
Will the Y chromosome disappear in the future?
This is a topic of scientific debate. The Y chromosome has lost many genes over evolutionary time compared to the X chromosome, leading some researchers to speculate that it may eventually disappear. However, the genes that remain on the Y chromosome, particularly those involved in sex determination and fertility, are highly conserved and show little sign of further loss. Most geneticists believe the Y chromosome has stabilised and is unlikely to vanish in the foreseeable future.
How is 47,XYY syndrome diagnosed and what does it mean for my child?
47,XYY syndrome is usually identified through karyotyping, either prenatally (if chromosomal analysis is performed for another reason) or postnatally during investigation for developmental concerns. Many boys with 47,XYY have no significant medical problems and lead typical lives. Some may be taller than average or experience mild learning or language delays. If your child is diagnosed with 47,XYY, your NHS clinical genetics team or paediatrician can provide tailored information and coordinate any additional support that may be helpful.